Nanobodies are fragments of antibodies found in camelids such as camels, dromedaries and alpacas. They can recognize and bind antigens and are smaller than conventional antibodies. Nanobodies hold several advantages over conventional monoclonal antibodies such as higher stability, thermal resistance and easier production. Growing prevalence of various types of cancers has increased the demand for advanced treatment options such as receptor-targeted therapies.
